Investigator Site

Birmingham, Alabama 35294

0 studies enrolling now · 5 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura, Lupus Erythematosus, Systemic, Postoperative Pain, Rheumatoid Arthritis

Studies at this site

• Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura — Completed
• A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis — Completed
• A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis — Completed
• A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus — Completed
• Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty — Completed